2Bassand JP,Harem CW,Ardissino D,et ah Guidelines for the diag- nosis and treatment of non ST-segment elevation acute coronary syndromes[ J]. Eur Heart J,2007,28 : 1598 - 1660.
3Wijns W,Kolh P,Danchin N,et al. Guidelines on myocardial revas- cularization [ J ]. European Heart Journal ,2010,31,2501 - 2555.
4Yusuf S, Mehta SR, Chrolavicius S, et al. Effects of fonda-parinux on mortality and reinfarction in patients with acute ST-segment eleva- tion myocardial, infarction : the OASIS-6 randomized trial [ J]. JA- MA ,2006,295 : 1519 - 1530.
5FUTUR/OASIS-8 Trial Group. Low-dose vs standard-dose unfrac- tionated heparin for percutaneous coronary in terventtion in acute coronary syndromes treated with fondaprinux:the FUTUR/OASIS-8 randomized trial [ J ] JAMA ,2010,304 ( 12 ) : 1339 - 1349.
6Steg G, James S, Atar D, et al. ESC guidelines for the management of acute myocardial infarction in patients presenting wilh ST-segment elevation:The Task Force on the management of ST-segment eleva- tion acute myocardial infarction of the European Society of Cardiolo- gy (ESC) [J]. Eur Heart J,2012.
8Sabatine M S,Cannon C P,Gibson C M,et al.The long-term prognostic value of optimal timely percutaneous coronary intervention after fibrinolysis for acute myocardial infraction[J].ACTA Universitatis Medicinalis Nanjing(Natural Science),2014,34(6):766-771.
9Armstrong P W,Boden W E.Reperfusion paradox in ST segment elevation myocardial infarction[J].Ann Intern Med,2011,155(6):389-391.
10Sánchez P L,Fernández-Avilés F.Routine early coronary angioplasty after thrombolysis in acute ST-elevation myocardial infarction:lysis is not the final step[J].Eur Heart J,2011,32(8):927-930.
